JP2024504136A5 - - Google Patents
Info
- Publication number
- JP2024504136A5 JP2024504136A5 JP2023543460A JP2023543460A JP2024504136A5 JP 2024504136 A5 JP2024504136 A5 JP 2024504136A5 JP 2023543460 A JP2023543460 A JP 2023543460A JP 2023543460 A JP2023543460 A JP 2023543460A JP 2024504136 A5 JP2024504136 A5 JP 2024504136A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021900114A AU2021900114A0 (en) | 2021-01-19 | Novel bicyclic peptipes | |
| AU2021900114 | 2021-01-19 | ||
| PCT/AU2022/050023 WO2022155704A1 (en) | 2021-01-19 | 2022-01-19 | Novel bicyclic peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024504136A JP2024504136A (ja) | 2024-01-30 |
| JP2024504136A5 true JP2024504136A5 (https=) | 2025-01-27 |
| JPWO2022155704A5 JPWO2022155704A5 (https=) | 2025-01-27 |
Family
ID=82548163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543460A Pending JP2024504136A (ja) | 2021-01-19 | 2022-01-19 | 「新規な二環式ペプチド」 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240117005A1 (https=) |
| EP (1) | EP4281486A4 (https=) |
| JP (1) | JP2024504136A (https=) |
| KR (1) | KR20230146025A (https=) |
| CN (1) | CN117062842A (https=) |
| AU (1) | AU2022209878A1 (https=) |
| CA (1) | CA3208598A1 (https=) |
| IL (1) | IL304545A (https=) |
| WO (1) | WO2022155704A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121108243A (zh) * | 2025-01-03 | 2025-12-12 | 中国药科大学 | 一种非核糖体多肽化合物及其合成基因簇bnp37和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1452868A2 (en) * | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| US10585100B2 (en) * | 2015-04-30 | 2020-03-10 | Kyoto University | Method of predicting effect of treatment by PD-1/PD-L1 blockade using abnormality of PD-L1 (CD274) as index |
| WO2017072280A1 (en) * | 2015-10-30 | 2017-05-04 | Affibody Ab | New polypeptide having affinity to pd-l1 |
| WO2018115203A1 (en) * | 2016-12-23 | 2018-06-28 | Bicyclerd Limited | Peptide derivatives having novel linkage structures |
| CN111936509A (zh) * | 2018-01-15 | 2020-11-13 | 艾比克斯治疗私人有限公司 | 蛋白质分子及其用途 |
| JP2019189591A (ja) * | 2018-04-27 | 2019-10-31 | 日東電工株式会社 | ヒトｐｄ−ｌ１結合性ペプチド |
| US12551567B2 (en) * | 2018-12-21 | 2026-02-17 | Bicyclerd Limited | Bicyclic peptide ligands specific for PD-L1 |
-
2022
- 2022-01-19 KR KR1020237027582A patent/KR20230146025A/ko active Pending
- 2022-01-19 CA CA3208598A patent/CA3208598A1/en active Pending
- 2022-01-19 EP EP22741955.3A patent/EP4281486A4/en active Pending
- 2022-01-19 AU AU2022209878A patent/AU2022209878A1/en active Pending
- 2022-01-19 JP JP2023543460A patent/JP2024504136A/ja active Pending
- 2022-01-19 CN CN202280022296.XA patent/CN117062842A/zh active Pending
- 2022-01-19 US US18/273,200 patent/US20240117005A1/en active Pending
- 2022-01-19 WO PCT/AU2022/050023 patent/WO2022155704A1/en not_active Ceased
-
2023
- 2023-07-18 IL IL304545A patent/IL304545A/en unknown